PE-backed SGH Healthcaring buys Rovipharm and RR Plastiques

The acquisitions are the first undertaken by SGH since it was acquired by the PE firms in January 2018.

As a result of the acquisition, SGH expects to generate a turnover of €40m in 2018.

Founded in 1985, SGH designs, develops and manufactures plastic products for the pharmaceutical industries and the health sector. Its client base includes Novartis, Sanofi Aventis, Bristol-Myers Squibb and Danone. The company's headquarters are in Saint Marcellin and it employs 90 staff.

While Gimv and Mérieux opted to make their initial investment in Stiplastics Healthcaring without leverage in January, this double acquisition was supported by a financing package provided by Bluebay.

As part of this transaction, RR Plastiques' previous parent company Medicos will retain RR Plastiques' minor applications for the cosmetic industry.

Company
Rovipharm, founded in 2006 and based in Val-Revermont, is a medication dosage pipettes specialist.

RR Plastiques produces droppers to dispense ear- and eye-care solutions. The business is based in Corveissiat and was founded in 1985.

People
Gimv – Benoit Chastaing (partner).
Mérieux Développement – Jean-François Billet (senior partner).
SGH Healthcaring group – Jérôme Empereur (chairperson, CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Portfolio management
• France
• Healthcare
• France
• Build-up